Close this search box.

The Drive to Deprescribe Initiative – Optimizing Medication Use in the Post-Acute and Long-Term Care Setting


  • Dr. Jennifer Pruskowski, PharmD, MS, BCPS, BCGP – Associate Director for Education and Evaluation, Pittsburgh Geriatric Research Education and Clinical Center, Pittsburgh Veterans Affairs Healthcare System
  • Dr. Arif Nazir, MD, FACP, CMD, AGSF – Chief Medical Officer for Signature Healthcare in Louisville, Kentucky, Founder and Chief Medical Officer for Care Ascend
  • Dr. Chad Worz, PharmD, BCGP, FASCP – Chief Executive for the American Society of Consultant Pharmacists

November 30, 2021 | 2PM ET / 11AM PT

The Post-Acute and Long-Term Care (PA-LTC) is arguably the most at need population, but one of the most challenging implementation setting for deprescribing. In early 2020, the Society for Post-Acute and Long-Term Care Society (formerly AMDA) sponsored the Drive to Deprescribe (D2D) initiative and was developed to address the unique deprescribing-related needs of PA-LTC residents and providers alike. This session is designed to:

  1. Describe the deprescribing conundrum in the PA-LTC setting;
  2. Present the D2D initiative; and
  3. Discuss interim aggregate data and lessons learned from the D2D initiative.


Contact Us

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.